Join the conversation
Drop your email in the form below, and you will receive our medtech articles as soon as they're published.
I had the privilege of interviewing the Value Analysis Whisperer himself, Mark Copeland, who cracked open the black box of Value Analysis Committees and shared the secrets that MedTech companies need ...
Quick 510(k) = Quick exitÂ
Right?
Not quite.
Â
Here's some interesting data:Â
SVB: 2019 Trends in Healthcare Investments and Exits
Â
Ok, the data is a bit dated. But the push for the quick 51...
Written by Eric Sugalski
I know what you're thinking - this is a sales pitch in disguise. Not the case. The intention of this article is to help you understand when to steer clear of outsourcing. And...
Written by Eric Sugalski
Consider this analogy..  You are driving across the US, planning for a week to travel from coast to coast. With elevated gas prices you want to optimize for fuel consumption....
- Written by Aidan Hyde & Eric Sugalski
Defining the right use case, ensuring a positive user experience, and mitigating user related risks are critical parts of the medical device design process. In...
Most companies avoid primary market research. They believe that in-house tribal knowledge is enough to make the key product and business decisions. Research would just tell the team what they already ...
Hey – Eric here.
Here are 4 steps on how to clearly define the clinical outcome that compels adoption of your new medical device.
Today’s issue of Medtech Mindset takes about 3 minutes to read.
Enj...
Consider a medical device startup, facing a critical market decision:
Should the company go big, aiming for the $1B market out of the gate? Or should the company go small, proving value with an initi...
Written by Eric Sugalski and Ulrich Herken
True story.
A medical device manufacturer developed an at-home wearable defibrillator for populations at high risk of sudden cardiac death. This device was...
Clinical use is a significant milestone for most medical device companies. Investors often see this milestone as a significant de-risking activity – one that can come with valuation bumps and subseque...
Written by Eric Sugalski
It’s a critical decision that defines your commercial strategy – but it’s one that is often taken without carefully weighing the pros and cons of each route.
What are the mo...
New technology is one of the primary drivers of growth in the medical device industry. Developing new tech can be long, iterative, and expensive -- so it is understandable that companies secure patent...